ACKO bets IRDAI distribution reforms will strengthen its D2C renewal economics

ACKO CEO Animesh Das says proposed IRDAI commission and distribution reforms could favour the insurer’s direct-to-consumer model, where renewals have near-zero acquisition cost. Health now contributes nearly half of its portfolio, while renewals account for more than half overall.

— Source published Sun, 16 Aug, 2026, 17:32 IST · First seen Sun, 16 Aug, 2026, 17:53 IST · Source Financial Express · BrandWagon

What happened

ACKO General Insurance · ACKO CEO Animesh Das says proposed IRDAI commission and distribution reforms could favour its D2C model, where renewals carry near-zero

Key facts

  • 85% compliance for insurance in first four years
  • Commercial vehicles account for more than 50% of third-party claims
  • 80% of five-year insurance buyers did not renew in the sixth year
  • Expense of management ratio improved by roughly 10% annually
  • More than half of ACKO's portfolio is renewal business
  • Health accounts for nearly 50% of ACKO's portfolio

Why this matters

ACKO’s potential channel-cost advantage makes it a more strategic partner or target in digital insurance, while increasing pressure on intermediated distributors with higher renewal acquisition costs.

What to watch

  • Final IRDAI language on commissions, expenses of management, distributor remuneration, and insurer distribution responsibilities.
  • ACKO disclosures on renewal share, health mix, renewal rates, loss ratios, and contribution-margin trajectory.
  • Evidence that banks, brokers, aggregators, or incumbent insurers alter commission structures or digital-retention offers after reforms.
  • Changes in health claims turnaround, complaint rates, servicing costs, and policy persistency.
  • Whether new-business growth is funded through materially higher marketing incentives despite the renewal-led profitability narrative.
  • Prioritize retention analytics, automated renewal journeys, and claims-service improvements in health, where renewal value and customer trust are most consequential.
  • Use lower renewal acquisition costs to selectively improve pricing or benefits rather than broadly increasing customer-acquisition spend.
  • Build assisted digital servicing for complex health renewals to protect retention as the portfolio shifts toward health.
  • Prepare compliance, remuneration, and distribution-reporting systems for multiple final IRDAI rule outcomes.
  • Measure cohort-level renewal margin after claims, servicing, discounts, and regulatory compliance costs to validate the D2C advantage.